JZP 361 structure
|
Common Name | JZP 361 | ||
---|---|---|---|---|
CAS Number | 1680193-80-9 | Molecular Weight | 405.880 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 611.7±65.0 °C at 760 mmHg | |
Molecular Formula | C22H20ClN5O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 323.8±34.3 °C |
Use of JZP 361JZP-361 is a potent and reversible inhibitor of human recombinant MAGL (hMAGL, IC50=46 nM), and has almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50=7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50=1.79 μM). JZP-361 represents a dual-acting pharmacological tool possessing both MAGL inhibitory and antihistaminergic activities[1]. |
Name | [4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl](1H-1,2,4-triazol-1-yl)methanone |
---|---|
Synonym | More Synonyms |
Description | JZP-361 is a potent and reversible inhibitor of human recombinant MAGL (hMAGL, IC50=46 nM), and has almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50=7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50=1.79 μM). JZP-361 represents a dual-acting pharmacological tool possessing both MAGL inhibitory and antihistaminergic activities[1]. |
---|---|
Related Catalog | |
Target |
H1 Receptor:6.81 (pA2) |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 611.7±65.0 °C at 760 mmHg |
Molecular Formula | C22H20ClN5O |
Molecular Weight | 405.880 |
Flash Point | 323.8±34.3 °C |
Exact Mass | 405.135651 |
LogP | 3.88 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.725 |
[4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl](1H-1,2,4-triazol-1-yl)methanone |
Methanone, [4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]-1H-1,2,4-triazol-1-yl- |